Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies-Reference-Cited by-同舟云学术

Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies

Author:

Bonsu Janice M.¹,Kola-Kehinde Onaopepo¹,Kim Lisa¹,Ruz Patrick¹,Campbell Courtney M.¹,Brammer Jonathan E.²,Addison Daniel¹³

Affiliation:

1. Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio

2. Division of Hematology, James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio

3. Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

Reference5 articles.

1. Cancer statistics, 2021.;Siegel;CA Cancer J Clin,2021

5. US Food and Drug Administration. Drugs@FDA. Accessed March 30, 2021. https://www.accessdata.fda.gov/scripts/cder/daf/.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献